Articles

Business school outgrows Indiana

With enrollment surging in vocational schools around the country, Indiana Business College has launched an expansion into
Ohio and likely into other states as well. The Indianapolis-based for-profit school also is changing its name.

Read More

Indiana Business College outgrows state-WEB ONLY

With enrollment surging in vocational schools around the country, Indiana Business College has launched an expansion into Ohio and likely into other states as well.  And the Indianapolis-based for-profit school is changing its name-to Harrison College, with a nod toward two U.S. presidents with Hoosier ties. Executives of the privately owned college informed staff and […]

Read More

Climbing enrollment boosts ITT profit-WEB ONLY

ITT Educational Services Inc. hurdled over analysts’ estimates with its first-quarter profit and raised its 2009 profit forecast by 50 cents per share, the company announced this morning. The Carmel-based operator of career and technical schools boosted profits 45 percent, to nearly $62 million, in the three months ended March 31, compared with the same […]

Read More

Judge blocks launch of generic Lilly drug-WEB ONLY

A federal judge in Indianapolis blocked today’s planned launch of a generic version of Evista, an osteoporosis and breast cancer drug made by Indianapolis-based Eli Lilly and Co. Sarah Evans Barker granted Lilly a preliminary injunction against Israel-based Teva Pharmaceuticals Industries Ltd. In March, Teva said it would wait until April 23 to launch its […]

Read More

WellPoint earnings exceed analyst expectations-WEB ONLY

Investors yawned this morning after WellPoint Inc. reported slightly lower first-quarter profits that soared above analysts’ expectations. In late-morning trading, WellPoint’s share price hovered near yesterday’s closing price of $41.76. The Indianapolis-based health insurer earned $1.62 per share, excluding investment losses, in the three months ended March 31. That marked a 43-percent rise from the […]

Read More

WellPoint earnings exceed analyst expectations-WEB ONLY

Investors yawned this morning after WellPoint Inc. reported slightly lower first-quarter profits that soared above analysts’ expectations. In late-morning trading, WellPoint’s share price hovered near yesterday’s closing price of $41.76. The Indianapolis-based health insurer earned $1.62 per share, excluding investment losses, in the three months ended March 31. That marked a 43-percent rise from the […]

Read More

Analyst: Expect prasugrel OK by end of April-WEB ONLY

Eli Lilly and Co. should win regulatory approval for its blood-thinner prasugrel by the end of the month, according to one Wall Street analyst. Dr. Tim Anderson, an analyst at Sanford C. Bernstein & Co., made the prediction in a note to investors on Tuesday. He added that Wall Street expects prasugrel to receive full approval, despite being dogged […]

Read More

WellPoint profit slowed by investment losses-WEB ONLY

Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 Investment losses caused profit to fall at WellPoint Inc. in the first quarter, and the company lowered its profit forecast for the year. The Indianapolis-based health insurer earned $580 million in the three months ended March 31, a 1-percent decline from the same quarter a year […]

Read More

Lubbers leading candidate for education post-WEB ONLY

State Sen. Teresa Lubbers is a leading candidate to become Indiana’s next commissioner of higher education, she confirmed through a spokeswoman today. She declined to comment further until an official announcement is made tomorrow. The Commission for Higher Education will meet at 11:15 a.m. to make its decision. Lubbers, a Republican from Indianapolis, would replace […]

Read More

Lilly gets lift after earnings rise 21 percent-WEB ONLY

Eli Lilly and Co. saw only a slight bump in its share price this morning after reporting first quarter profit that exceeded analysts’ expectations by 21 percent. The Indianapolis-based drugmaker said part of that increase was caused by the rapid rise of the value of the U.S. dollar against foreign currencies. The benefit isn’t likely […]

Read More

Big investor pushes for Lilly to buy Amylin-WEB ONLY

Eli Lilly and Co. would buy San Diego-based biotech company Amylin Pharmaceuticals Inc. if corporate raider Carl Icahn gets his way. Icahn, a major investor in Amylin, is pushing for an immediate sale of the company to Indianapolis-based Lilly, according to a letter written by Amylin’s lead independent director, James N. Wilson. Amylin and Lilly […]

Read More

Lilly posts $1.3B profit, topping expectations-WEB ONLY

Eli Lilly and Co.’s profit soared above analysts’ expectations in the three months ended March 31. The Indianapolis-based drugmaker reported earnings per share of $1.20 this morning, well above the 99 cents Wall Street analysts had predicted, according to a survey by Thomson Financial. Lilly said first-quarter profit was $1.3 billion, up 24 percent from […]

Read More

Bennett draws up education game plan-WEB ONLY

Tony Bennett, Indiana’s new superintendent of public instruction, speaks like a coach in the locker room at halftime. During an interview with IBJ, he got up from his chair, went to the man-size white board a few paces from his desk, and vigorously drew arrows and Venn diagrams to drive home his points. Just 100 […]

Read More

Half of state’s schools fail progress report-WEB ONLY

Only half of Indiana’s public schools met federal rules for “adequate yearly progress” this year, down from 54 percent a year ago – when the standards for success were lower, the Indiana Department of Education announced today. About 83 percent of school corporations met the standard, which comes from the No Child Left Behind Act […]

Read More

Half of state’s schools fail progress report-WEB ONLY

Only half of Indiana’s public schools met federal rules for “adequate yearly progress” this year, down from 54 percent a year ago – when the standards for success were lower, the Indiana Department of Education announced today. About 83 percent of school corporations met the standard, which comes from the No Child Left Behind Act […]

Read More

Could health reform bite Lilly harder than most?-WEB ONLY

When it comes to health care reform, Eli Lilly and Co. has its derriere exposed more than its drugmaker peers. That’s according to a recent report by Jason Napodano, a senior pharmaceutical analyst at Zack’s Equity Research. In an April 9 report, he examined potential negatives in President Barack Obama’s health care reform outline. While […]

Read More

WellPoint to sell subsidiary for $4.6B

WellPoint Inc. has
agreed to sell its pharmacy benefits management arm for $4.675 billion in cash and stock to St. Louis-based Express Scripts,
the companies announced April 13.

Read More